SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

AUROBINDO PHARMA

BSE: 524804 28 Jun 2025
Healthcare
₹ 1099.3
Aurobindo Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

AUROBINDO PHARMA - Share Price & Details

Market Cap
₹64,289
High /Low
1,593 / 994.0
Stock P/E
18.4
Book Value
₹557.0
Dividend Yield
0.41
ROCE
14.3
ROE
₹11.2
Face Value
1.0
PEG Ratio
4.61
EVEBITDA
₹8.97
Debt
8,263
CMP / FCF
10,341
Debt to equity
₹0.25
NP Ann
3,484
High price all time
1,593
Piotroski score
₹5.0
Graham Number
864.0
No. Eq. Shares
58.6
Net CF
₹2,169
Net profit
3,484
Price to book value
1.97
Interest Coverage
₹12.1
Low price all time
10.1
Industry PE
32.0
Reserves
₹32,595
Free Cash Flow
₹1,408

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
AUROBINDO PHARMA LTD.NANANANA64,28918.4
FORTIS HEALTHCARE LTD.4134.6-422.33884.7-0.565918970.2
Alkem Laboratories LimitedNANANANA5707426.4

Peer Comparison Chart


About AUROBINDO PHARMA

Aurobindo Pharma Ltd., with Security Code 524804, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Five medium-term triggers that can contribute to a 35% upside in Aurobindo Pharma shares

(20 Jun 2025)
Aurobindo Pharma Ltd. shares have the potential to rise nearly 35% from its previous closing price, as per brokerage firm Nuvama's note on...
Read more →

Market Experts' LIVE Stock Recommendations: Hold Garden Reach, Buy Aurobindo Pharma

(18 Jun 2025)
Reliance Securities' Vikas Jain advises buying Torrent Power Ltd. with a stop loss at Rs 1,350 and a target price of Rs 1,545.
Read more →

Buy, Sell Or Hold: Garden Reach, Jyoti CNC, Aurobindo Pharma, Piccadily Agro, Reliance Power — Ask Profit

(17 Jun 2025)
Should you hold shares of Reliance Power Ltd.? Should you add shares of Piccadily Agro Industries Ltd. at the current market price?
Read more →

Aurobindo Pharma incorporates WoS in USA

(17 Jun 2025)
Aurobindo Pharma USA Inc. has incorporated a new wholly owned subsidiary in USA by the name of CRESEDEMO PHARMA LLC in order to expand the...
Read more →

AUROBINDO PHARMAS US ARM INCORPORATES CRESEDEMO PHARMA

(16 Jun 2025)
The purpose of incorporating this new entity is to expand the company's pharmaceutical products business in USA. The company has subscribed...
Read more →

AUROBINDO PHARMA’S US ARM INCORPORATES CRESEDEMO PHARMA

(16 Jun 2025)
The purpose of incorporating this new entity is to expand the company's pharmaceutical products business in USA. The company has subscribed...
Read more →